Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
34 participants
OBSERVATIONAL
2014-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
People with or without dry eye syndrome may enroll.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants
NCT00487838
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02875704
Corneal Nerve Structure in Sjogren's
NCT03203382
Rod and Cone Mediated Function in Retinal Disease
NCT02617966
Genetic Factors in Age-Related Macular Degeneration
NCT00058695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with Dry Eye Disease
Measures tear film stability, and visual function will be taken before and after a sustained silent reading task. The reading task will take place over 30 minutes, and a comprehension assessment will be given after reading. After completion of the reading task, measures of corneal sensation and structural imaging will be performed. The results from each of 3 cohorts will be compared to ascertain the differences between those populations with and without dry eye.
No interventions assigned to this group
Subjects with Sjogren's Syndrome
Measures tear film stability, and visual function will be taken before and after a sustained silent reading task. The reading task will take place over 30 minutes, and a comprehension assessment will be given after reading. After completion of the reading task, measures of corneal sensation and structural imaging will be performed. The results from each of 3 cohorts will be compared to ascertain the differences between those populations with and without dry eye.
No interventions assigned to this group
Healthy Controls
Measures tear film stability, and visual function will be taken before and after a sustained silent reading task. The reading task will take place over 30 minutes, and a comprehension assessment will be given after reading. After completion of the reading task, measures of corneal sensation and structural imaging will be performed. The results from each of 3 cohorts will be compared to ascertain the differences between those populations with and without dry eye.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capacity to give informed consent.
* Self-reported literacy (i.e. a "Yes" answer to the question "Have you learned how to read?")
* A previous diagnosis of dry eye syndrome by an eyecare specialist
* Ocular Surface Disease Index total scoring of 13 or above
\- A previous diagnosis of Sjögren's syndrome by an immunology specialist, per ACR criteria 22
* No previous history of dry eye diagnosis
* Ocular Surface Disease Index total scoring of 12 or under
* Total corneal and conjunctival staining score of 0
Exclusion Criteria
* Any ocular surgery within the last 3 months.
* Mental issues, illiteracy, or language problems which might possibly interfere with reading ability
* History of taking or current use of topical prescription anti-inflammatory eyedrops (including, cyclosporine and steroids as well as any glaucoma eyedrops). Subjects who are willing to discontinue their treatment for at least a period of 30 days can be placed on a "wash out period" as per the discretion of the investigator and subject safety, and be eligible at the end of this period, given all other criteria have been met. Otherwise, subjects on these medications will be excluded.
50 Years
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Holly Hindman
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holly B Hindman, MD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester, Flaum Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00048640
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.